Value Demonstration (Arsenal) Acquires Guidemark Health
November 2, 2021
Arsenal Capital Partners, through its Value Demonstration healthcare platform, has acquired Guidemark Health, a U.S.-based healthcare marketing communications, training, and medical education agency. The acquisition is the third add-on to Arsenal’s Value Demonstration organization and is intended to deepen the platform’s customer engagement, medical communications, and oncology/rare disease capabilities.
- Targets
- Guidemark Health
- Platforms
- Value Demonstration (Arsenal Capital Partners platform)
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Arsenal Capital Partners Acquires Majority Stake in OncoHealth; McKesson Makes Strategic Investment
May 9, 2022
Healthcare Services
Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.
-
Arsenal's Value Demonstration Acquires Zipher Medical Affairs
January 10, 2022
Healthcare Services
Arsenal Capital Partners' Value Demonstration business acquired Zipher Medical Affairs, a Marion, Massachusetts-based medical affairs strategic consulting firm that specializes in oncology. The add-on expands Value Demonstration's medical affairs, MSL optimization, and launch-readiness capabilities as part of its integrated healthcare services platform.
-
Arsenal's Value Demonstration Business Acquires Cyan Health
December 8, 2021
Healthcare Services
Arsenal Capital Partners' Value Demonstration business has acquired Cyan Health, a Montclair, New Jersey–based payer marketing and market-access agency. The add-on strengthens Arsenal's Value Demonstration platform capabilities in market access, payer communications, and value demonstration to support life sciences clients and accelerate patient access to new therapies.
-
Arsenal Capital Partners Acquires BresMed Health Solutions
February 26, 2020
Healthcare Services
Arsenal Capital Partners acquired BresMed Health Solutions as the first investment to form a new value demonstration platform focused on market access, health economics, outcomes research, patient preference and real-world evidence. BresMed — a global health economics and outcomes research consultancy with more than 150 staff across the U.K., Ireland, the Netherlands, the U.S. and India — will continue to be led by founder Nic Brereton and will join Arsenal’s new platform led operationally by Jon Williams.
-
Leonard Green & Partners Leads Recapitalization of WCG with Arsenal and Novo Holdings
November 14, 2019
Healthcare Services
An investor group led by Leonard Green & Partners, in partnership with Arsenal Capital Partners and Novo Holdings A/S, has agreed to recapitalize WCG to provide resources to accelerate growth and expand capabilities in clinical trial optimization. Financial terms were not disclosed; the transaction was announced in November 2019 and expected to close in the first quarter of 2020.
-
Arsenal Capital Partners Acquires Caprion Biosciences from GHO Capital
July 31, 2019
Healthcare Services
Arsenal Capital Partners has acquired Caprion Biosciences from GHO Capital Partners LLP. Caprion is a specialist laboratory services provider focused on immune monitoring (flow cytometry) and quantitative proteomics for pharmaceutical and biotech R&D, with facilities across North America, Europe and Australia.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.